world
health
organ
express
increas
concern
bird
flu
character
pose
seriou
risk
caus
human
pandem
issu
highlight
scientif
press
present
small
number
fatal
occur
infect
chicken
human
rare
human
human
transfer
form
allow
readi
infect
human
occur
accord
viru
potenti
infect
least
global
popul
effort
made
develop
convent
virusbas
vaccin
product
process
rel
slow
number
specialist
produc
small
expect
past
pandem
global
spread
would
occur
month
approxim
period
requir
vaccin
product
hen
egg
favor
condit
togeth
brief
clinic
studi
requir
europ
world
capac
influenza
vaccin
million
unit
monoval
vaccin
produc
europ
difficult
countri
without
capac
put
virusbas
vaccin
product
place
possibl
pandem
increas
product
probabl
occur
slowli
wider
gener
vaccin
interpandem
period
develop
million
dose
reduc
one
inject
normal
amount
requir
need
protect
new
human
strain
california
type
becom
press
addit
candid
virusbas
vaccin
prepar
usabl
antigen
differ
occur
applic
stock
remain
uncertain
potenti
drug
avail
even
smaller
scale
variabl
effect
differ
strain
background
dna
vaccin
global
interest
sinc
principl
might
possibl
produc
mani
industri
site
present
commerci
influenza
dna
vaccin
though
human
trial
viru
success
phase
ulmer
note
wide
varieti
small
anim
studi
dna
vaccin
flu
promis
sinc
review
sobol
colleagu
report
particlemedi
influenza
dna
vaccin
hors
larg
anim
success
though
activ
differ
respons
compar
viral
infect
discuss
later
issu
size
dose
dna
vaccin
need
human
consider
mass
crucial
particularli
detail
patent
applic
concept
influenza
dna
vaccin
publish
human
trial
dna
vaccin
hiv
ebola
viru
malaria
also
way
kodih
colleagu
show
dna
vaccin
encod
hemagglutinin
could
provid
protect
immun
influenza
viru
infect
mice
also
note
plasmid
dna
could
defin
time
latest
infect
tissu
estim
match
dna
vaccin
could
prepar
cultur
month
isol
initi
dna
viru
requir
contain
normal
circumst
would
take
number
year
novel
form
vaccin
progress
point
would
appli
human
popul
howev
acceler
human
trial
could
contempl
heavi
fatal
virul
strain
threaten
pandem
show
potenti
continu
outrun
convent
vaccin
suppli
would
major
medic
social
regulatori
polit
issu
rais
equal
critic
would
suppli
dna
vaccin
kilogram
scale
necessari
influenza
pandem
dna
vaccin
would
need
cheaper
better
convent
vaccin
must
capabl
fast
product
particular
aim
review
explor
feasibl
use
exist
plant
manufactur
hand
compani
unit
state
europ
expertis
facil
platform
strain
manufactur
dna
vaccin
clinic
grade
standard
probabl
one
two
current
capac
produc
quantiti
could
address
whole
popul
experi
swine
flu
potenti
pandem
us
suggest
would
extrem
difficult
govern
suppli
flu
vaccin
other
pandem
nation
fulli
cover
similarli
may
possibl
licens
strain
patent
knowhow
given
relev
commerci
vaccin
target
requir
negoti
seem
like
occur
press
emerg
exist
purpos
paper
address
process
issu
would
face
outsid
small
group
current
compani
produc
plasmid
dna
trial
identifi
relev
literatur
technic
challeng
discuss
public
patent
cite
give
great
deal
detail
summar
would
essenti
basi
process
plan
signific
gap
publish
knowledg
present
paper
also
either
provid
foundat
make
choic
defin
gap
final
compani
capac
larg
scale
manufactur
specif
dna
vaccin
potenti
time
build
tailor
capac
necessari
identifi
exist
type
facil
might
switch
neither
like
biopharmaceut
protein
nonpenicillin
antibiot
plant
ideal
could
principl
appli
biopharmaceut
plant
locat
us
europ
great
major
recombin
protein
product
rather
plasmid
dna
situat
front
end
ferment
recoveri
system
partli
applic
though
oxygen
heat
transfer
capac
may
alway
gear
usual
e
coli
sourc
plasmid
dna
purif
stage
current
biopharmaceut
facil
heavili
chromatograph
rel
much
larger
size
plasmid
dna
capac
column
match
need
also
possibl
principl
mammalian
cell
facil
protein
product
could
util
virusbas
vaccin
option
consid
though
vaccin
would
first
choic
closer
exist
safe
product
technolog
even
demand
dna
vaccin
harder
transfer
beyond
biopharmaceut
facil
main
pharmaceut
capac
global
antibiot
ferment
common
relev
downstream
process
domin
liquidliquid
extractor
resinbas
ion
exchang
hydrophob
sorptiondesorpt
addit
regulatori
practic
penicillin
product
facil
use
product
concern
cross
contamin
impact
penicillinallerg
patient
number
actual
test
allerg
much
smaller
patient
number
report
case
anaphylaxi
per
million
becom
signific
potenti
pandem
vaccin
antibiot
pose
lesser
problem
remain
issu
plant
revalid
would
requir
inde
would
formal
facil
signific
antibiot
capac
would
need
retain
least
deal
microbi
infect
secondari
influenza
rel
speak
global
capac
high
larg
uncertainti
potenti
dose
probabl
plasmid
dna
titer
would
achiev
practic
nontailor
plant
much
larger
scale
current
use
less
experienc
oper
address
discuss
final
uptak
vaccin
popul
hard
predict
like
depend
risk
perceiv
individu
pandem
viru
versu
previous
unus
vaccin
type
reason
paper
comment
issu
ferment
scale
scale
princip
relev
antibiot
facil
would
one
avail
contin
could
also
potenti
process
larg
amount
quickli
valu
facil
use
would
need
oper
pharmaceut
sector
good
manufactur
practic
gmp
equal
staff
experienc
issu
produc
pharmaceut
product
could
address
challeng
even
would
difficult
unless
detail
input
experienc
commerci
plasmid
process
greatest
scale
challeng
would
occur
initi
plasmid
dna
recoveri
oper
also
case
convent
purif
method
would
stretch
sever
public
review
aspect
larger
scale
prepar
plasmid
dna
eg
ref
particularli
ref
howev
none
explor
specif
bioprocess
engin
issu
rais
product
ferment
scale
util
exist
industri
plant
regulatori
issu
heart
pharmaceut
process
review
plasmid
dna
address
bear
use
exist
facil
process
materi
produc
need
meet
regulatori
guidelin
fda
http
wwwfdagovcbergdlnsplasdnavachtm
would
also
parallel
assess
safeti
current
guidelin
virusbas
vaccin
pandem
http
wwwemeaeuintpdfshumanvwp
might
requir
implement
switch
plant
use
necessarili
knowledg
field
dna
vaccin
properti
plasmid
dna
involv
key
contamin
briefli
summar
main
altern
process
rout
extract
also
summar
two
method
mani
variant
use
prepar
plasmid
dna
laboratori
first
lysozym
use
prepar
spheroplast
e
coli
lyse
brief
heat
near
boil
point
presenc
deterg
usual
triton
second
major
rout
util
sodium
hydroxid
deterg
sodium
dodecyl
sulfat
sd
lysi
result
materi
neutral
potassium
acet
lead
floccul
precipit
choos
correct
ph
equival
sodium
hydroxid
concentr
chromosom
dna
togeth
protein
irrevers
denatur
neutral
recov
plasmid
larg
desir
supercoil
form
clarifi
liquor
suspens
repres
feedstock
purif
process
laboratori
perform
cell
ferment
harvest
resuspend
typic
concentr
gl
wet
weight
follow
two
altern
method
cell
lysi
varieti
laboratori
method
use
produc
pure
plasmid
dna
classic
method
involv
precipit
cesium
chlorid
gradient
centrifug
nbutanol
phenol
extract
suscept
scaleup
method
analysi
plasmid
dna
contamin
address
recent
form
plasmid
requir
coval
close
supercoil
one
contamin
includ
molecul
nick
one
strand
open
circl
form
strand
near
junction
linear
form
give
idea
size
linear
plasmid
base
pair
kb
molecular
weight
da
length
supercoil
plasmid
probabl
kb
would
involv
dna
vaccin
influenza
plasmid
would
contain
pathogenderiv
sequenc
though
could
like
propos
viralbas
vaccin
alter
sequenc
given
cell
solid
protein
rna
plasmid
dna
level
challeng
purif
larg
e
coli
chromosom
dna
repres
cell
solid
contamin
properti
potenti
close
plasmid
dna
addit
level
e
coli
lipopolysaccharid
reduc
endotoxin
euml
less
euml
demand
e
coli
strain
consider
bear
outcom
ideal
select
high
product
situat
larg
number
patient
might
eventu
treat
especi
crucial
potenti
dna
integr
human
chromosom
avoid
therefor
prather
colleagu
note
care
taken
choic
insert
avoid
homolog
sequenc
human
genom
plasmid
dna
promot
termin
region
also
care
select
restrict
biolog
activ
sequenc
insert
plasmid
global
pandem
situat
organ
like
come
agenc
compani
experienc
appropri
dna
scienc
technolog
like
virusbas
vaccin
repres
intern
consensu
plasmid
dna
much
larger
molecular
structur
protein
less
compact
suscept
shear
forc
depend
plasmid
size
plasmid
dna
kilobas
kb
smaller
effect
less
seriou
oper
shearinduc
damag
larg
chromosom
e
coli
dna
suffer
chromosom
dna
degrad
approach
size
plasmid
dna
materi
difficult
remov
one
virtu
alkalin
lysi
denatur
chromosom
e
coli
dna
mostli
form
singl
strand
differ
significantli
supercoil
doublestrand
plasmid
dna
separ
properti
clinic
trial
prepar
plasmid
dna
small
select
group
well
describ
method
prepar
clinic
grade
materi
suffic
though
subsequ
chang
address
larger
quantiti
pose
regulatori
problem
whole
popul
target
ferment
scale
mean
downstream
process
step
must
good
capac
discuss
oper
chromatographi
expand
bed
adsorpt
becom
less
attract
addit
larg
scale
potenti
simultan
global
demand
consum
reagent
chromatograph
media
must
avail
commerci
substanti
scale
prefer
produc
manufactur
number
countri
command
govern
rule
though
cost
less
issu
pandem
simpl
process
reagent
attract
facilit
rapid
progress
larg
scale
purif
rout
plasmid
dna
figur
subject
patent
probabl
sensibl
choos
attract
respect
avail
plant
howev
earli
capac
licens
knowhow
patent
uncertain
prepandem
period
patent
concern
appli
could
influenc
choic
emerg
technolog
could
improv
individu
process
step
consider
better
centrifug
design
superior
chromatograph
expand
bed
media
altern
membranebas
anion
exchang
adsorb
perform
describ
much
detail
current
distribut
limit
local
avail
influenc
process
choic
first
challeng
grow
plasmid
dnacontain
e
coli
effici
larg
scale
possibl
indic
commerci
product
recombin
insulin
use
organ
though
detail
ferment
public
avail
e
coli
grown
scale
defin
medium
engin
studi
report
scale
scale
particularli
detail
account
scaleup
given
junker
specif
regard
e
coli
cover
scale
l
note
comparison
myceli
broth
common
antibiot
plant
might
use
rheolog
less
import
scaleup
base
achiev
minimum
dissolv
oxygen
level
recommend
though
scale
ferment
conduct
defin
medium
major
smaller
scale
studi
use
yeast
extract
simpl
salt
carbon
nitrogen
sourc
gener
balanc
advantag
disadvantag
defin
media
commerci
ferment
review
fedbatch
mode
shown
yield
higher
cell
densiti
consequ
higher
volumetr
product
plasmid
dna
may
facil
less
easili
achiev
voss
colleagu
note
rel
high
product
batch
ferment
mgl
ammonium
chlorid
supplement
medium
chartrain
note
earlier
use
monosodium
glutam
also
replac
due
qualiti
concern
nh
oh
function
ph
control
nitrogen
sourc
feed
glycerol
solut
medium
contain
neomycin
oxygen
uptak
carbon
dioxid
evolut
rate
measur
onlin
thiamin
ammonium
glycerol
offlin
chang
carbon
nitrogen
balanc
increas
plasmid
yield
semidefin
medium
medium
effect
cell
resuspens
alkalin
lysi
fedbatch
mode
advantag
product
supercoil
plasmid
stabl
longer
period
batch
ferment
help
term
downstream
process
larg
scale
harvest
occupi
longer
period
chartrain
show
rel
constant
specif
yield
h
cultiv
time
l
ferment
fed
h
rozkov
colleagu
use
continu
cultur
method
shown
resist
gene
plasmid
vector
place
significantli
higher
oxygen
demand
necessit
lower
feed
rate
highdens
cultur
plasmidfre
cultur
becom
bigger
issu
scale
e
coli
high
cell
densiti
product
plasmid
dna
reflect
differ
cell
densiti
especi
batch
fedbatch
gl
dri
weight
batch
gl
fedbatch
prather
colleagu
summar
plasmid
dna
product
valu
laboratori
small
pilot
plant
rang
mgl
compani
special
plasmid
dna
product
attain
yield
much
gram
per
liter
ferment
broth
achiev
equal
attent
construct
strain
medium
ferment
condit
higher
level
also
rest
use
defin
medium
tailor
strain
specif
yield
plasmid
per
mass
cell
high
total
dri
weight
cell
per
liter
need
except
reduc
downstream
solid
load
ideal
pandem
situat
best
strain
would
avail
medium
known
place
lower
yield
plasmid
dna
necessari
assumpt
strain
avail
highli
select
medium
yeast
extract
may
appropri
global
suppli
yeast
extract
fairli
wide
distribut
ferment
broth
main
harvest
option
centrifug
membranebas
crossflow
microfiltr
ultrafiltr
classic
filtrat
bacterium
e
coli
constrain
cell
size
floccul
agent
appli
tend
interfer
product
lysi
e
coli
harvest
disk
centrifug
observ
prematur
lysi
pronounc
defin
media
may
anoth
factor
favor
yeast
extract
medium
detail
studi
indic
prematur
lysi
princip
associ
cell
discharg
underflow
stream
accompani
addit
intracellular
damag
reveal
flow
cytometri
measur
gerard
chan
et
al
unpublish
addit
hold
cell
h
reduc
supercoil
content
substanti
increas
contamin
due
prematur
cell
membran
lysi
larger
disk
machin
may
produc
better
result
new
design
disk
machin
also
reduc
effect
autom
discharg
tubular
centrifug
produc
less
damag
machin
also
less
common
centrifug
perform
data
e
coli
cell
harvest
shown
tabl
laboratori
pilot
studi
conduct
frozen
past
differ
robust
fresh
cell
direct
ferment
form
materi
like
essenti
ferment
scale
freez
cell
previous
use
opportun
assess
qualiti
ferment
product
crossflow
microfiltr
becom
increasingli
common
biopharmaceut
antibiot
plant
case
use
near
front
end
process
capac
cell
harvest
sever
studi
crossflow
microfiltr
bacteria
publish
plasmid
dna
patent
mention
concentr
cell
ferment
use
tangenti
flow
filtrat
across
kda
nomin
molecular
weight
cutoff
membran
concentr
cell
diafilt
three
equival
volum
steril
salin
resuspend
od
nm
od
gl
dri
cell
weight
stratton
meagher
observ
ultrafiltr
membran
gave
higher
flux
rate
e
coli
microfiltr
membran
paper
measur
e
coli
flux
leav
asid
atyp
initi
rate
like
lm
h
cours
membranespecif
meyer
colleagu
observ
flux
reduct
cell
store
h
reduct
freez
thaw
alkalibas
chemic
process
alkalin
heat
lysi
describ
advantag
disadvantag
larg
scale
alkali
lysi
becom
difficult
engin
scale
increas
soon
sdsalkali
user
centrifug
supplier
familiar
equival
settl
area
character
machin
valu
given
simpli
multipli
equival
settl
area
give
flow
rate
l
h
correspond
solid
sediment
lefthand
column
mani
biopharmaceut
plant
process
mammalian
cell
valu
includ
valu
homogen
e
coli
cell
biopharmaceut
user
familiar
data
pilot
scale
intermitt
discharg
disk
machin
allow
shear
inher
valu
obtain
extrapol
appear
parenthes
other
obtain
interpol
probabl
function
b
penetr
cell
potenti
ph
damag
supercoil
plasmid
dna
batch
mix
intens
increas
precipit
chromosom
e
coli
dna
suscept
shear
damag
sever
paper
kinet
process
publish
ciccolini
colleagu
indic
shear
rate
neutral
optim
term
maximum
plasmid
dna
releas
avoid
excess
chromosom
dna
floc
breakdown
maximum
sd
precipit
contamin
result
obtain
laminar
flow
shear
field
neutral
potassium
acet
stream
need
cold
possibl
insolubil
contamin
scale
demand
signific
chill
capac
recent
impact
lysi
time
ph
mix
examin
studi
demonstr
sever
interest
featur
relat
larg
industri
scale
oper
ph
chang
littl
alkali
less
ad
may
feasibl
use
overal
alkali
molar
rather
potenti
unreli
ph
measur
condit
desir
provid
cell
concentr
maintain
constant
reason
naoh
molar
gap
irrevers
chromosom
denatur
damag
supercoil
plasmid
dna
gener
achiev
best
outcom
effect
ph
time
need
within
oper
window
variabl
togeth
defin
observ
bear
adopt
exist
industri
plant
sever
way
larg
scale
batch
mix
involv
increasingli
difficult
compromis
pilot
level
degre
amelior
tailor
mixer
design
feasibl
desir
scale
pandem
situat
exist
plant
taken
would
gener
option
howev
element
ideal
batch
mixer
may
feasibl
individu
facil
first
use
low
power
number
impellor
desir
possibl
sever
shaft
helic
ribbon
mixer
also
option
larg
marin
impellor
reason
effect
individu
impellor
diamet
prefer
greater
half
vessel
diamet
second
sever
feed
point
wellmix
region
around
distal
end
one
impellor
particular
challeng
alkalin
lysi
sudden
increas
viscos
format
sticki
precipit
envelop
agit
essenti
agit
underpow
slow
high
viscos
baffl
help
must
stand
free
vessel
side
avoid
dead
zone
absenc
specialist
impellor
sever
separ
mixer
may
appli
higher
ph
strongli
enhanc
shearinduc
dna
degrad
necessari
err
side
stronger
mix
avoid
extrem
ideal
mix
would
continu
brief
period
high
shear
follow
condit
low
shear
though
scale
increas
even
mix
continu
system
take
longer
recogn
wan
colleagu
full
gain
come
potassium
acet
also
ad
subsequ
continu
mode
increas
engin
complex
patent
link
wan
describ
small
pilot
continu
flow
system
continu
inject
neutral
lysat
batch
collect
vessel
agit
preform
floc
consequ
solidliquid
separ
flotat
see
compani
manufactur
larg
scale
inlin
mixer
kind
would
need
treat
multim
volum
howev
degre
engin
modif
exist
plant
nontrivi
similar
result
could
achiev
setup
shown
figur
exist
pipelin
tank
use
also
potenti
allow
alkali
potassium
acet
stream
smaller
concentr
degre
agit
two
tank
must
adequ
avoid
signific
bypass
fluid
explor
approach
recent
pilot
scale
though
still
need
manag
mix
fill
first
tank
system
workabl
publish
procedur
period
hold
prior
neutral
minut
mean
interpos
hold
line
tank
heatinduc
lysi
addit
earli
literatur
patent
describ
continu
heat
treatment
stainless
steel
tube
maintain
follow
min
less
cool
tubular
system
visibl
clog
tube
occur
industri
scale
heat
exchang
common
mani
plant
though
complex
intern
may
lead
higher
risk
blockag
one
advantag
method
volum
lysat
increas
disadvantag
purif
method
chromosom
dna
produc
mostli
doublestrand
form
addit
patent
note
yield
plasmid
dna
reduc
time
lysozym
omit
also
seem
case
reduct
throughput
need
longer
hold
time
pandem
situat
avail
recombin
lysozym
use
would
issu
watson
note
heat
lysi
repres
process
cost
lysozym
account
major
cost
process
need
control
well
temperatur
plasmid
degrad
e
coli
deoxyribonucleas
degrad
genom
dna
evid
fulli
denatur
viscos
cell
suspens
initi
cp
nsm
rose
cp
nsm
lysi
procedur
use
triton
rather
sd
employ
alkali
kresheck
altschul
file
patent
altern
deterg
note
triton
sd
degrad
time
plate
heat
exchang
system
relev
type
describ
higgin
colleagu
treat
mechan
disrupt
e
coli
remov
rna
found
necessari
use
wide
space
plate
increas
heat
transfer
area
hot
water
rather
steam
could
use
heat
medium
threestag
arrang
use
heat
achiev
two
stage
resid
time
use
first
previous
heat
process
liquor
regener
stage
second
water
regener
stage
cool
achiev
chill
water
heat
cool
media
pass
crossflow
wang
et
al
made
detail
studi
heat
method
without
lysozym
conclud
capabl
compar
yield
alkalisd
procedur
paper
provid
viscos
data
kinet
model
lysi
neutral
alkalin
lysat
achiev
harvest
scale
shearsensit
floc
gl
wet
weight
difficult
thatcher
colleagu
describ
use
bag
filter
woven
nylon
stainless
steel
hous
filter
avail
scale
contempl
nienow
et
al
indic
follow
filtrat
via
depth
filter
patent
describ
mix
g
diatomac
earth
l
neutral
lysat
filter
precoat
paper
min
l
recov
measur
larg
amount
bodi
feed
gl
versu
usual
gl
also
gravityf
wherea
pressur
feed
barg
normal
precoat
would
typic
kgm
filter
area
total
neutral
lysat
suspens
filter
flux
rate
varieti
filter
cloth
mesh
filter
aid
rel
low
solid
extrus
avoid
averag
lm
h
ceas
hour
filter
blind
observ
without
filter
aid
precoat
process
would
improv
bodi
feed
filter
aid
degre
rotari
vacuum
filtrat
high
knife
cut
rate
observ
cell
debri
meet
biopharmaceut
cgmp
rotari
vacuum
filter
would
need
enclos
design
use
handl
solvent
sometim
employ
blood
plasma
fraction
adsorpt
plasmid
dna
diatomac
earth
occur
ph
aid
avoid
presenc
dival
ion
mask
complex
agent
even
level
mm
potassium
ion
mm
sodium
ion
mm
ammonium
ion
lead
loss
adsorpt
requir
process
revalid
mean
filtrat
medium
cloth
ideal
dispos
much
inaccess
surfac
area
term
larg
scale
filtrat
possibl
lesson
learn
human
plasma
fraction
number
use
rotat
vertic
leaf
filter
de
jong
colleagu
describ
background
though
larg
scale
detail
wolter
describ
use
vertic
rotat
discharg
precoat
filter
bodi
feed
gl
diatomac
earth
mm
precoat
heatethanol
isol
albumin
plasma
yield
flux
rate
lm
h
pore
filter
element
suspens
recircul
clariti
achiev
filtrat
surfac
l
total
volum
l
feed
recov
filtrat
recoveri
could
increas
wash
contamin
problem
gentl
natur
stress
johnston
colleagu
describ
use
cellulos
filter
aid
human
plasma
fraction
found
concentr
cellulos
wv
best
note
need
allow
time
cellulos
swell
patent
show
filtrat
achiev
turbid
lower
centrifug
though
even
wash
yield
less
pressur
drop
across
filter
rose
accord
fine
cellulos
bar
result
plate
frame
filter
rotat
vertic
leaf
filter
similar
data
relat
filter
area
given
scour
problem
diatomac
earth
pump
centrifug
electropolish
surfac
relev
also
potenti
centrifug
separ
dispos
filter
aid
recombin
e
coli
residu
scale
contempl
would
nontrivi
floc
separ
flotat
ten
liter
scale
wright
colleagu
observ
hand
equival
floc
sank
howev
observ
breakup
floc
strongli
agit
reactor
air
salt
cold
potassium
acet
associ
floc
driven
strong
mix
bottom
liquor
flotat
studi
low
particul
gl
howev
though
filter
higher
rate
unsettl
floc
percentag
contamin
chromosom
dna
also
higher
probabl
full
floc
deposit
filter
act
secondari
filter
aid
l
scale
bottom
liquor
could
collect
product
floc
lost
signific
pandem
situat
speed
product
would
critic
also
loss
solid
stream
disk
centrifug
use
breul
recent
report
flotat
procedur
enhanc
applic
vacuum
patent
pend
note
pilot
scale
l
oper
enhanc
floc
flotat
air
follow
vacuum
deaerat
use
larg
scale
industri
pressur
vessel
vacuum
line
avail
mani
pharmaceut
facil
recent
examin
use
disk
centrifug
recoveri
neutral
alkalin
lysat
readili
recov
yield
supernat
low
solid
od
centrifug
perform
data
given
tabl
show
compar
good
outcom
term
sediment
fraction
hold
space
usabl
modest
import
achiev
high
clariti
subsequ
stage
effect
small
increas
degrad
plasmid
isoform
lower
molecular
weight
speci
observ
increas
flow
rate
centrifug
shear
discharg
solid
problem
discharg
liquid
phase
contain
plasmid
caus
signific
damag
earlier
observ
substanti
damag
plasmid
dna
autom
discharg
tubular
centrifug
relat
discharg
supernat
watson
indic
centrifug
consid
potenti
preliminari
polish
filtrat
heat
lysi
process
one
option
would
appli
liquor
obtain
beneath
float
floc
centrifug
multichamb
machin
given
solid
content
gl
l
scale
larg
solid
capac
machin
may
abil
polish
substanti
volum
machin
shear
entri
rotor
rise
substanti
scale
recoveri
liquid
phase
crossflow
microfiltr
advantag
centrifug
avoid
loss
centrifug
underflow
preliminari
studi
made
crossflow
microfiltr
unclarifi
neutral
lysat
small
pilot
system
suggest
promis
howev
sandberg
colleagu
heat
lysat
inher
continu
natur
larg
scale
heat
lysi
process
suggest
direct
linkag
continu
flow
solidliquid
separ
natur
heat
coagul
materi
favor
subsequ
separ
provid
shear
degrad
higgin
colleagu
report
recoveri
heattreat
e
coli
homogen
materi
disk
centrifug
comparison
whole
e
coli
heattreat
materi
rapidli
interf
effici
machin
part
sludg
space
could
fill
bowl
open
achiev
good
clarif
see
tabl
howev
debri
remov
prior
step
may
led
stickier
lander
colleagu
use
filtrat
subsequ
ctab
hydrat
calcium
silic
adsorpt
step
recircul
filtrat
achiev
clariti
use
pressur
air
displac
liquor
key
featur
high
perform
achiev
follow
lysi
solidliquid
separ
need
purifi
supercoil
plasmid
dna
product
impur
includ
nick
linear
form
well
remain
chromosom
dna
protein
rna
endotoxin
laboratori
scale
accomplish
either
immedi
progress
chromatographi
pilot
scale
varieti
lower
resolut
separ
step
prior
chromatographi
includ
precipit
membran
separ
batch
sorptiondesorpt
data
oper
even
patent
claim
scaleup
relev
involv
solidliquid
separ
use
highspe
centrifug
therefor
qualiti
supernat
much
higher
achiev
industri
scale
centrifug
use
lysat
harvest
affect
subsequ
step
caution
thu
requir
use
data
assess
larg
scale
perform
particular
colloid
foul
reduc
crossflow
membran
rate
adsorb
chromatograph
capac
filtrat
give
clarifi
lysat
closer
achiev
laboratori
centrifug
given
capac
conduct
solidliquid
separ
shearsensit
solid
precipit
method
deal
larg
volum
plasmid
dna
purif
method
may
precipit
either
plasmid
contamin
former
result
dissolut
step
need
may
repres
point
potenti
shearinduc
yield
loss
intens
mix
requir
plasmid
dna
precipit
poli
ethylen
glycol
cetyltrimethylammonium
bromid
unattract
larg
scale
flammabl
precipit
poli
ethylen
glycol
peg
sensit
size
molecul
make
agent
valuabl
separ
plasmid
dna
larger
chromosom
dna
select
precipit
impur
rang
salt
lithium
chlorid
sodium
acet
ammonium
acet
sulfat
calcium
chlorid
use
promis
describ
lithium
chlorid
would
favor
potenti
toxic
metal
ion
ctab
fraction
precipit
reagent
ctab
use
mani
year
plasmid
purif
recent
patent
publish
use
follow
lysozymeheat
lysi
procedur
follow
paper
compani
complementari
inform
reagent
heat
lysi
found
capabl
first
precipit
chromosom
linear
open
circl
plasmid
dna
follow
remov
plasmid
dna
could
precipit
prior
rna
endotoxin
protein
precipit
done
presenc
filter
aid
level
ctab
need
chromosom
dna
later
plasmid
dna
precipit
assess
particl
size
probe
analyz
detect
format
larg
aggreg
filter
aid
precipit
import
precis
level
ctab
vari
exampl
level
lysi
agent
wv
ctab
precipit
contain
gl
diatomac
earth
batch
yield
g
plasmid
filtrat
nutschetyp
stir
filter
tank
use
cm
diamet
stainless
steel
mesh
cake
wash
reslurri
refilt
watson
show
overal
yield
step
found
critic
remov
rna
wash
mm
nacl
prior
dissolut
dna
allow
subsequ
hydrat
calcium
silic
adsorpt
remov
remain
trace
rna
stir
nutsch
advantag
easi
resuspens
cake
stainless
steel
mesh
cleanabl
way
cloth
devic
produc
least
filtrat
area
pharmaceut
facil
capac
larg
batch
filtrat
suit
approach
lander
colleagu
describ
subsequ
extract
second
ctab
precipit
contain
princip
plasmid
dna
increas
sodium
chlorid
concentr
measur
viscos
possibl
detect
point
plasmid
dna
solubil
leav
contamin
insolubl
step
yield
ctab
patent
note
altern
alkalin
lysi
step
may
use
sd
omit
alkalin
step
prevent
interfer
ctabinduc
dna
precipit
howev
sd
contribut
speed
alkalin
lysi
format
insolubl
floc
irrevers
denatur
chromosom
dna
protein
addit
potassium
acet
gani
colleagu
analyz
condit
format
sdsctabdna
ternari
complex
show
though
complex
solubl
case
doublestrand
dna
neutral
ph
insolubl
higher
ph
case
heat
lysi
chromosom
dna
remain
doublestrand
therefor
solubl
ternari
complex
studi
batch
ctab
precipit
clarifi
neutral
alkalisd
lysat
observ
precipit
total
nucleic
acid
subsequ
filtrat
rate
lm
h
diatomac
earth
examin
centrifug
altern
filtrat
use
cellulos
powder
coprecipit
avoid
scour
tabl
level
cellulos
adjust
gl
avoid
occupi
much
bowl
space
occur
gl
foam
discharg
gl
precipit
eonduv
colleagu
compar
effect
ammonium
acet
sulfat
sodium
sulfat
tripotassium
citrat
calcium
chlorid
precipit
rna
show
latter
superior
gave
rna
remov
lab
centrifug
clarifi
lysat
well
protein
reduct
remov
chromosom
dna
endotoxin
reduct
ph
critic
need
avoid
larg
plasmid
loss
condit
calcium
chlorid
ph
min
found
optim
accompani
paper
show
complementar
crossflow
ultrafiltr
procedur
remov
low
molecular
weight
rna
patent
describ
use
solid
ammonium
sulfat
satur
would
difficult
centrifug
industri
machin
due
salt
densiti
step
follow
logic
revers
phase
chromatographi
possibl
precipit
genom
dna
peg
plasmid
dna
cross
tangenti
flow
microfiltr
separ
refer
lysat
harvest
public
focus
use
ultrafiltr
molecular
fraction
eonduv
colleagu
publish
laboratori
scale
descript
rna
remov
method
show
need
low
ionic
strength
diafiltr
fraction
rna
permeat
retain
plasmid
dna
least
diafiltr
volum
requir
rna
clearanc
show
plasmid
dna
load
increas
mgm
percentag
residu
rna
rose
lysat
explor
kda
protein
membran
found
advantag
larger
pore
patent
evid
degre
upstream
concentr
polar
strong
influenc
composit
permeat
even
lower
molecular
weight
cutoff
membran
plasmid
lost
without
polar
layer
conclud
prior
calcium
chlorid
precipit
necessari
achiev
good
remov
rna
crossflow
ultrafiltr
membran
use
remov
contamin
includ
protein
calcium
chlorid
patent
employ
earlier
treatment
ribonucleas
easier
remov
degrad
rna
occur
studi
latter
author
observ
higher
plasmid
retent
experi
calcium
chlorid
pretreat
liquor
kda
membran
note
use
calcium
chlorid
compact
plasmid
dna
group
note
need
consider
wash
recov
plasmid
membran
state
plasmid
load
gm
membran
area
neither
gave
flux
versu
time
profil
howev
kahn
colleagu
use
kda
membran
oper
constant
transmembran
pressur
psi
bar
retent
flow
lm
h
observ
flux
rate
lm
h
bussey
colleagu
use
lower
molecular
weight
ultrafiltr
kda
later
stage
diafiltr
possibl
prior
remov
high
molecular
weight
rna
may
allow
flux
higher
kda
membran
use
deliber
gel
polar
kda
uf
membran
use
concentr
expand
bed
anion
exchang
purif
feasibl
use
convent
biopharmaceut
method
purif
rest
scale
avail
system
earliest
point
procedur
could
appli
clarifi
neutral
lysat
expand
bed
advantag
toler
particul
materi
hydrat
calcium
silic
adsorpt
purif
ctabtreat
materi
use
hydrat
calcium
silic
describ
chromosom
dna
opencircular
plasmid
bind
greater
affin
conform
constrain
supercoil
plasmid
level
gg
total
dna
naci
plasmid
pure
state
bind
larg
displac
back
solut
chromosom
dna
reduc
ww
plasmid
least
h
oper
must
slow
allow
requir
balanc
adsorpt
impur
endotoxin
reagent
ctab
also
remov
select
bind
hydrat
calcium
silic
solid
remov
filtrat
watson
record
level
less
ctab
final
product
step
yield
though
sever
global
manufactur
list
hydrat
calcium
silic
necessarili
meet
pharmaceut
specif
appli
also
diatomac
earth
plasmid
dna
precipit
ethanol
steril
filter
yield
ctab
procedur
clinic
grade
materi
puriti
hydrat
calcium
silic
scour
way
diatomac
materi
disk
centrifug
principl
option
anion
exchang
patent
describ
anion
exchang
bind
expand
bed
bag
filter
extract
l
anion
exchang
medium
feed
l
lysat
treat
ribonucleas
linear
flow
cmh
patent
describ
possibl
need
recycl
complet
plasmid
dna
bind
bed
wash
remov
particul
elut
done
downward
flow
chromatographi
use
l
eluat
dilut
appli
two
l
column
option
deterg
triton
tween
vv
ad
aid
remov
endotoxin
ferreira
colleagu
also
examin
expand
bed
recoveri
anion
exchang
oper
upward
linear
flow
cmh
expand
bed
height
cm
elut
nacl
downward
flow
cm
h
rna
protein
breakthrough
high
molecular
weight
rna
chromosom
dna
plasmid
dna
form
elut
later
singl
peak
load
one
sediment
column
volum
equival
lysat
attempt
medium
clog
channel
eas
insert
intermedi
propanol
precipit
step
conclud
situat
less
justif
expand
bed
oper
differ
perspect
ref
may
due
latter
use
ribonucleas
consequ
degrad
rna
possibl
lower
ionic
strength
load
publish
exampl
realli
larg
scale
expand
bed
separ
rare
eg
ref
column
cm
diamet
cm
fed
l
ferment
broth
contain
recombin
protein
dilut
reduc
ionic
strength
feed
rate
lh
equival
cmh
linear
flow
rate
eonduv
burk
conduct
detail
laboratori
studi
anion
exchang
chromatographi
media
note
other
tenticular
medium
gain
capac
allow
access
larg
macromolecul
media
design
high
poros
next
effect
form
care
adjust
condit
resolut
plasmid
dna
rna
achiev
maximum
dynam
capac
gl
paper
emphas
need
prepurif
propos
calcium
chlorid
precipit
crossflow
membran
separ
patent
bhikhabhai
use
calcium
chlorid
precipit
prior
two
stage
anion
exchang
presenc
calcium
chlorid
alter
charg
rna
readili
elut
leav
dna
bound
plasmid
separ
chromosom
dna
second
anion
exchang
use
shallow
gradient
linear
flow
rate
cmh
note
load
strong
anion
exchang
cmh
elut
plasmid
step
preced
alkalin
lysi
filtrat
diafiltr
peg
ammonium
acet
isopropyl
precipit
centrifug
separ
silicabas
anion
exchang
describ
applic
clinic
trial
scale
purif
summar
use
proprietari
composit
depth
filter
produc
accept
materi
evid
least
g
plasmid
util
kgkg
wet
weight
biomass
breul
indic
materi
complet
separ
rna
plasmid
dna
chromatograph
expand
bed
method
capac
key
issu
particularli
molecul
larg
plasmid
dna
dynam
capac
breakthrough
pack
bed
anion
exchang
given
gl
supercoil
plasmid
dna
clarifi
lysat
prepurif
howev
peg
fraction
precipit
bind
capac
higher
paper
note
capac
convent
expand
bed
adsorb
diamet
mgl
plasmid
dna
patent
result
given
support
use
poli
ethylen
glycol
compact
agent
anion
exchang
plasmid
dna
peg
effect
retain
feed
lysat
preprecipit
sequenti
peg
ammonium
acet
propanol
recent
new
gener
ion
exchang
membran
develop
higher
capac
plasmid
dna
like
less
wide
avail
global
event
pandem
anion
exchang
chromatographi
media
access
repres
attract
altern
term
capac
haber
colleagu
show
dynam
capac
dna
reduc
increas
flow
rate
membran
capac
volum
per
volum
term
approxim
order
magnitud
higher
correspond
resin
classic
ion
exchang
materi
avail
without
chromatographi
system
appropri
scale
batch
adsorpt
stir
system
follow
recoveri
exchang
filtrat
basket
centrifug
option
basic
studi
batch
adsorpt
plasmid
dna
made
gel
filtrat
horn
colleagu
appli
gel
filtrat
lysat
previous
purifi
filtrat
precipit
ammonium
acet
precipit
concentr
diafiltr
propanol
precipit
feed
small
pilot
scale
column
filter
fed
cmh
load
volum
less
total
column
supercoil
product
emerg
column
volum
ferreira
colleagu
compar
two
gel
filtrat
media
prepurif
peg
ammonium
acet
precipit
lab
centrifug
without
effect
prepurif
presenc
contamin
rna
reduc
flow
rate
resolut
varley
colleagu
use
ribonucleas
appli
gel
filtrat
load
column
volum
achiev
good
resolut
plasmid
dna
rna
stage
preced
ultrafiltrationbas
concentr
chromatograph
method
though
affin
method
gener
exclud
analysi
ground
could
wide
avail
quickli
metal
affin
may
except
basic
chelat
adsorb
avail
major
produc
metal
salt
simpl
reagent
adsorb
bind
singlestrand
oligonucleotid
rna
hydrophob
interact
chromatographi
also
occasion
appli
recent
plasmid
dna
chromatographi
review
also
summar
elsewher
shear
sensit
plasmid
dna
chromosom
dna
especi
precipit
contain
mean
compon
pump
throttl
valv
caus
great
damag
behavior
respect
precipit
vari
pump
type
manner
protein
precipit
peristalt
pump
caus
least
damag
screw
pump
especi
centrifug
pump
throttl
valv
caus
much
lander
colleagu
note
problem
filter
ethanol
final
precipit
suggest
precipit
past
centrifug
ad
ethanol
mix
high
speed
homogen
rotor
stator
past
simultan
dehydr
wet
mill
hard
particl
amen
filtrat
dri
also
note
materi
produc
aid
hydrat
calcium
silic
contain
calcium
indic
remov
edta
conjunct
ultrafiltr
precipit
finish
formul
heavili
influenc
mean
deliveri
use
issu
shear
sensit
plasmid
dna
loom
larg
oper
inject
vial
purif
loss
step
steril
filtrat
larg
flexibl
macromolecul
substanti
kong
et
al
unpublish
found
plasmid
dna
loss
steril
filtrat
poli
vinyliden
difluorid
membran
vari
linearli
molecular
weight
size
kb
loss
significantli
chang
flux
membran
lm
h
concentr
watson
note
similar
trend
observ
gl
plasmid
solut
filter
area
need
drop
supercoil
plasmid
content
rose
plasmid
kb
stabil
ship
storag
also
import
lyophil
appli
shear
damag
must
avoid
schleef
privat
commun
volkin
colleagu
describ
formul
condit
materi
detail
logist
altern
process
illustr
exampl
literatur
tabl
data
linearli
extrapol
scale
suspend
cell
small
pilot
scale
volum
report
direct
comparison
must
made
caution
particularli
data
tabl
relat
initi
cell
concentr
nearli
twice
high
tabl
process
may
also
supersed
howev
give
indic
volum
involv
quantiti
reagent
adsorb
chromatograph
media
impact
process
volum
alkalin
lysi
rout
clear
compar
tabl
altern
rout
beyond
lysi
use
precipit
volum
could
doubl
howev
initi
downstream
volum
origin
ferment
volum
harvest
step
chang
scale
tabl
interest
though
base
prectab
process
patent
data
footnot
ad
indic
column
volum
base
simpl
linear
extrapol
origin
lysat
clarifi
lysat
diafilt
kda
membran
treat
ribonucleas
rediafilt
filter
load
anion
exchang
reduc
versu
expand
bed
tabl
use
newer
gener
porou
chromatograph
media
reflect
much
smaller
requir
volum
absorb
purif
method
would
benefit
use
ribonucleas
degrad
high
molecular
weight
rna
bovin
ribonucleas
exclud
safeti
ground
possibl
use
known
strain
e
coli
express
ribonucleas
clear
fedbatch
desir
mode
ferment
lysi
valu
use
lower
volum
heat
lysi
rest
capac
achiev
larg
scale
treatment
heat
exchang
prefer
access
recombin
lysozym
altern
alkalin
lysi
could
appli
plant
larg
scale
may
hard
control
term
prefer
solidliquid
separ
cell
harvest
crossflow
microfiltr
avoid
cell
damag
caus
disk
centrifug
discharg
problem
cell
resuspens
centrifug
neutral
lysat
prove
workabl
also
applic
liquor
beneath
float
floc
filtrat
attract
ctabdiatomac
earth
recoveri
hydrat
calcium
silic
remov
disk
centrifug
use
newer
process
scheme
convent
type
use
membranebas
method
fraction
diafiltr
allow
reduct
singl
anion
exchang
chromatograph
step
perhap
relev
factor
use
exist
crossflow
microfiltr
centrifug
system
pandem
context
expect
flux
compar
materi
machin
normal
oper
antibiot
plant
may
larg
cellular
aggreg
fungal
pellet
smaller
cell
streptomycet
biopharmaceut
plant
largest
cell
mammalian
tabl
allow
centrifug
comparison
though
mani
disk
centrifug
antibiot
plant
involv
liquidliquid
separ
threephas
machin
convert
solidliquid
clarifi
chang
ring
dam
diamet
though
riser
channel
disk
may
optim
postlethwait
colleagu
note
previou
microfiltr
report
steadyst
flux
baker
yeast
lm
h
concentr
gl
yeast
bovin
serum
albumin
present
solubl
compon
gl
membran
pore
size
yeast
repres
exist
biopharmaceut
process
eukaryot
biopharmaceut
antibiot
plant
larg
continu
harvest
capabl
antibiot
plant
note
major
downstream
oper
gear
small
molecul
howev
microfiltr
ultrafiltr
use
cell
harvest
product
scale
relev
flux
avail
centrifug
filter
later
stage
vari
product
plant
depth
filtrat
recombin
protein
princip
secondari
clarif
solid
residu
contamin
rather
product
protein
process
use
disk
centrifug
larg
crossflow
microfilt
front
end
train
solidliquid
separ
impli
harvest
separ
postlysi
precipit
potenti
ctab
hydrat
calcium
silic
precipit
achiev
reus
centrifug
microfilt
chromatograph
system
unders
plasmid
dna
especi
exist
initi
step
protein
product
use
affin
chromatographi
reduc
requir
subsequ
capac
seem
like
less
ideal
oper
nonpurposedesign
plant
especi
solidliquid
separ
puriti
per
stage
poorer
necessari
add
step
base
differ
separ
mechan
expand
bed
chromatograph
method
rest
type
media
avail
older
less
sophist
materi
produc
poorer
separ
though
cost
would
primari
consider
pandem
watson
note
reduct
capit
use
ctab
hydrat
calcium
silic
procedur
reflect
simplic
equip
use
reduc
cost
divid
lysi
precipit
adsorpt
final
diafiltr
latter
somewhat
larger
other
compar
convent
process
chromotographi
repres
half
cost
probabl
upper
ferment
yield
gl
maximum
recoveri
downstream
kgm
effect
dose
observ
recent
phase
trial
routin
influenza
dna
vaccin
use
gold
particl
deliveri
howev
viru
previous
experienc
human
popul
higher
dose
may
requir
per
dose
may
reason
estim
indic
milligram
plasmid
dna
need
without
special
deliveri
agent
level
could
contempl
rang
option
term
particul
adjuv
reduc
wong
colleagu
shown
dna
vaccin
influenza
deliv
mice
intranas
use
liposomeencapsul
plasmid
dna
comparison
dose
three
hemagglutinin
antigen
virusbas
vaccin
expect
virusbas
vaccin
singl
dose
unlik
suitabl
consid
naiveti
popul
regard
pandem
viru
adjuv
may
need
fedson
http
www
evid
prime
dna
follow
boost
proteinbas
vaccin
effect
combin
need
two
dose
could
way
use
virusbas
vaccin
sparingli
dna
vaccin
best
case
million
dosesm
ferment
broth
relat
process
may
possibl
howev
without
detail
knowhow
tailor
facil
overal
yield
onefifth
perhap
reason
dose
assum
overal
yield
gm
million
dosesm
would
avail
infer
figur
uncertainti
overal
ferment
capac
mani
countri
would
need
order
ten
quickli
address
popul
rather
front
line
group
process
cycl
week
distribut
immun
time
perhap
week
period
week
develop
immun
overal
cycl
quit
long
relat
pandem
suggest
antibiot
plant
commonli
ferment
capac
could
repres
way
achiev
necessari
speed
well
facil
mani
countri
could
address
harvest
lysi
clarif
ctab
precipit
recoveri
plasmid
solid
could
purifi
smaller
facil
filtrat
equip
capabl
process
quantiti
common
chemic
pharmaceut
facil
could
play
role
biopharmaceut
sector
media
mammalian
cell
cultur
ship
quantiti
steril
also
critic
issu
one
signific
differ
e
coli
materi
would
could
viabl
recombin
cell
present
howev
materi
ship
due
precaut
issu
would
much
prefer
best
process
deliveri
technolog
avail
negoti
present
analysi
assum
singl
plasmid
code
one
antigen
howev
known
gene
influenza
viru
strong
impact
outcom
one
gene
may
benefici
pose
challeng
either
repeat
process
care
blend
larger
plasmid
higher
shear
sensit
set
new
process
constraint
use
dior
polycistron
construct
coexpress
multipl
antigen
may
eas
problem
recent
studi
suggest
oxygen
demand
ferment
unaffect
plasmid
size
concern
intrins
dna
structur
may
differ
plasmid
would
impact
process
recent
studi
indic
seriou
effect
zdna
though
triplex
form
reduc
rel
amount
supercoil
plasmid
kb
plasmid
freez
thaw
note
virtual
step
subject
patent
case
new
technolog
associ
product
virusbas
vaccin
world
health
organ
stress
need
resolv
intellectu
properti
issu
prior
pandem
analyt
requir
though
similar
approach
biopharmaceut
protein
distinct
compani
unfamiliar
analyt
servic
exampl
contract
research
organ
could
necessari
achiev
speed
throughout
process
local
avail
high
grade
raw
materi
key
issu
possibl
command
key
materi
govern
countri
must
born
mind
present
almost
focu
pandem
plan
virusbas
vaccin
heart
intern
polici
manag
strain
chang
interpandem
year
also
repres
establish
technolog
unlik
posit
chang
unless
low
percentag
vaccin
cover
global
popul
becom
issu
virtu
virusbas
vaccin
organ
product
regul
clinic
use
establish
disadvantag
capac
respond
slow
cover
may
modest
challeng
dna
vaccin
present
process
setup
time
greater
need
clinic
test
analysi
conclud
process
necessari
scale
would
challeng
feasibl
short
immin
threat
hard
biopharmaceut
antibiot
compani
devot
time
issu
unless
govern
take
major
initi
potenti
gain
fast
product
dna
vaccin
relat
pandem
achiev
would
essenti
initi
taken
uncertain
situat
public
sector
bioprocess
engin
commun
least
help
prepar
ground
larg
scale
product
case
need
press
bioprocess
prioriti
emerg
analysi
detail
comparison
virtu
heat
versu
alkalin
lysi
relat
larg
scale
oper
inform
bear
perform
larg
scale
solidliquid
separ
sever
stage
central
addit
inform
effect
shear
forc
secondari
allpervas
oper
pump
finish
oper
lyophil
studi
stage
test
materi
reflect
real
process
condit
earlier
step
much
biochem
engin
involv
appli
dna
vaccin
come
use
major
diseas
malaria
hiv
prevent
author
would
welcom
comment
quarter
issu
rais
